COVID
Kathryn Edwards, MD
Professor of Pediatrics
Vanderbilt University Medical Center
Nashville, TN, United States
Bionet (Individual(s) Involved: Self): Consultant; CDC (Individual(s) Involved: Self): Research Grant or Support; IBM (Individual(s) Involved: Self): Consultant; Merck (Individual(s) Involved: Self): member DSMC, Other Financial or Material Support; Moderna (Individual(s) Involved: Self): member DSMC, Other Financial or Material Support; NIH (Individual(s) Involved: Self): Research Grant or Support; Pfizer (Individual(s) Involved: Self): member DSMC, Other Financial or Material Support; Roche (Individual(s) Involved: Self): member of DSMB, Other Financial or Material Support; Sanofi Pasteur (Individual(s) Involved: Self): member DSMB, Other Financial or Material Support; Sequiras (Individual(s) Involved: Self): Member DSMB, Other Financial or Material Support; X4 Pharmaceuticals (Individual(s) Involved: Self): Consultant
Roy Gulick, MD, MPH
Professor of Medicine
Chief, Division of Infectious Diseases
Weill Cornell Medicine
New York, NY, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mary Hayden, MD, FIDSA, FSHEA
Director, Division of Infectious Diseases; Director, Division of Clinical Microbiology, Professor of Medicine and Pathology
Rush University Medical Center
Chicago, IL, United States
Sanofi (Individual(s) Involved: Self): Advisor or Review Panel member
Andrew Pavia, MD
George and Esther Gross Presidential Professor
Chief, Division of Pediatric Infectious Diseases
University of Utah
Salt Lake City, UT, United States
Antimicrobial Therapy Inc (Individual(s) Involved: Self): Associate Editor; Merck, Sharpe, and Dohme (Individual(s) Involved: Self): Consultant; WebMD (Individual(s) Involved: Self): Consultant
Erica Hardy, MD, MMSc
Assistant Professor
Alpert Medical School of Brown University / Women & Infants Hospital
Providence, RI, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jason Gallagher, PharmD, FIDP, FCCP, FIDSA, BCPS
Clinical Professor
Temple University
Philadelphia, PA, United States
Astellas (Individual(s) Involved: Self): Speakers' bureau; Merck (Individual(s) Involved: Self): Consultant, Grant/Research Support; Nabriva: Consultant; Qpex (Individual(s) Involved: Self): Consultant; Shionogi (Individual(s) Involved: Self): Consultant
Deepali Kumar, MD, MSc, FRCPC
Professor of Medicine
University Of Toronto
Toronto, ON, Canada
Astellas (Individual(s) Involved: Self): Speakers' bureau; Atara Biotherapeutics (Individual(s) Involved: Self): Grant/Research Support; GSK (Individual(s) Involved: Self): Consultant, Grant/Research Support; Merck (Individual(s) Involved: Both Myself and my Spouse/Partner): Advisor or Review Panel member, Grant/Research Support; Oxford immunotec (Individual(s) Involved: Self): Consultant, Grant/Research Support; Pfizer (Individual(s) Involved: Self): Speakers' bureau; Roche (Individual(s) Involved: Self): Consultant, Grant/Research Support; Sanofi (Individual(s) Involved: Self): Advisor or Review Panel member; Shire/Takeda (Individual(s) Involved: Both Myself and my Spouse/Partner): Advisor or Review Panel member, Grant/Research Support
CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Creditâ„¢
MOC Credits: Maximum of 1.25 hours of MOC Credit
No CPE credits